BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 30391193)

  • 1. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.
    Fakhro M; Broberg E; Algotsson L; Hansson L; Koul B; Gustafsson R; Wierup P; Ingemansson R; Lindstedt S
    J Cardiothorac Surg; 2017 Nov; 12(1):100. PubMed ID: 29178919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
    Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
    Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Donor Arterial Partial Pressure of Oxygen on Outcomes After Lung Transplantation in Adult Cystic Fibrosis Recipients.
    Hayes D; Kopp BT; Kirkby SE; Reynolds SD; Mansour HM; Tobias JD; Tumin D
    Lung; 2016 Aug; 194(4):547-53. PubMed ID: 27272653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.
    Kapila A; Baz MA; Valentine VG; Bhorade SM;
    J Heart Lung Transplant; 2015 Jan; 34(1):65-74. PubMed ID: 25447585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients.
    Calhoun R; SivaSai KS; Sundaresan S; Trulock EP; Lynch JP; Patterson GA; Cooper JD; Mohanakumar T
    Transpl Int; 1999; 12(6):439-46. PubMed ID: 10654356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.
    Van Raemdonck D; Keshavjee S; Levvey B; Cherikh WS; Snell G; Erasmus M; Simon A; Glanville AR; Clark S; D'Ovidio F; Catarino P; McCurry K; Hertz MI; Venkateswaran R; Hopkins P; Inci I; Walia R; Kreisel D; Mascaro J; Dilling DF; Camp P; Mason D; Musk M; Burch M; Fisher A; Yusen RD; Stehlik J; Cypel M;
    J Heart Lung Transplant; 2019 Dec; 38(12):1235-1245. PubMed ID: 31777330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.
    Cebrià I Iranzo MÀ; Vos R; Verleden GM; Gosselink R; Langer D
    Arch Bronconeumol (Engl Ed); 2019 May; 55(5):239-245. PubMed ID: 30595421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation.
    Gao F; Chen J; Wei D; Wu B; Zhou M
    Front Med; 2018 Apr; 12(2):224-228. PubMed ID: 28752350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
    Fisher AJ; Wardle J; Dark JH; Corris PA
    J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.
    Lebeer M; Kaes J; Lambrech M; Vanstapel A; Beeckmans H; Ambrocio GPL; Vanaudenaerde BM; Verleden SE; Verbeken EK; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verleden GM; Vos R;
    Transpl Int; 2020 Feb; 33(2):216-228. PubMed ID: 31643104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
    Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
    J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.